Rock Springs Capital Management Cuts Holdings in Surgery Partners and Tarsus Pharma

Rock Springs Capital Management LP disclosed in its latest SEC 13F filing that it sold 102,000 shares of Surgery Partners, Inc. (NASDAQ:SGRY) in the first quarter, reducing its position to 208,000 shares, or about 0.16% of the company, worth roughly $2.5 million. The firm also trimmed its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) by selling 35,165 shares, leaving a holding of 225,179 shares, representing 0.52% of the company and valued at approximately $15.8 million.

These transactions reflect Rock Springs’ portfolio adjustments across two health‑care firms, while other institutional investors have been increasing their positions in both companies during recent quarters.